Published in Nutr Cancer on January 01, 1998
Processed meat and colorectal cancer: a review of epidemiologic and experimental evidence. Nutr Cancer (2008) 1.81
Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis (2003) 1.11
Meat processing and colon carcinogenesis: cooked, nitrite-treated, and oxidized high-heme cured meat promotes mucin-depleted foci in rats. Cancer Prev Res (Phila) (2010) 0.96
Endogenous N-nitroso compounds, and their precursors, present in bacon, do not initiate or promote aberrant crypt foci in the colon of rats. Nutr Cancer (2000) 0.94
Freeze-dried ham promotes azoxymethane-induced mucin-depleted foci and aberrant crypt foci in rat colon. Nutr Cancer (2010) 0.87
Calcium carbonate suppresses haem toxicity markers without calcium phosphate side effects on colon carcinogenesis. Br J Nutr (2010) 0.81
Heme-induced biomarkers associated with red meat promotion of colon cancer are not modulated by the intake of nitrite. Nutr Cancer (2013) 0.79
Calcium inhibits promotion by hot dog of 1,2-dimethylhydrazine-induced mucin-depleted foci in rat colon. Int J Cancer (2013) 0.78
Relation of meat, fat, and fiber intake to the risk of colon cancer in a prospective study among women. N Engl J Med (1990) 8.98
Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer (1975) 7.20
Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett (1987) 3.41
Intake of fat, meat, and fiber in relation to risk of colon cancer in men. Cancer Res (1994) 2.84
Sugar, meat, and fat intake, and non-dietary risk factors for colon cancer incidence in Iowa women (United States). Cancer Causes Control (1994) 2.33
Reconciling the epidemiology, physiology, and molecular biology of colon cancer. JAMA (1992) 2.02
Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst (1992) 1.88
Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett (1995) 1.85
Role of bile acids in colorectal carcinogenesis. Eur J Cancer (1995) 1.66
Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol Biomarkers Prev (1996) 1.54
Determination of serum iron and latent iron-binding capacity (LIBC). Clin Chim Acta (1971) 1.50
Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis (1995) 1.45
A prospective cohort study on the relation between meat consumption and the risk of colon cancer. Cancer Res (1994) 1.40
Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis (1992) 1.25
Promotion of colonic microadenoma growth in mice and rats fed cooked sugar or cooked casein and fat. Cancer Res (1990) 1.08
Ability of aberrant crypt foci characteristics to predict colonic tumor incidence in rats fed cholic acid. Cancer Res (1993) 1.06
Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J Natl Cancer Inst (1992) 1.02
A case-control study of diet and colorectal cancer in a multiethnic population in Hawaii (United States): lipids and foods of animal origin. Cancer Causes Control (1997) 1.01
Characterisation of aberrant crypt foci in carcinogen-treated rats: association with intestinal carcinogenesis. Br J Cancer (1995) 0.97
Nutritional and lifestyle habits and water-fiber interaction in colorectal adenoma etiology. Cancer Epidemiol Biomarkers Prev (1997) 0.97
Effect of type and amount of dietary fat and 1,2-dimethylhydrazine on biliary bile acids, fecal bile acids, and neutral sterols in rats. Cancer Res (1977) 0.96
The antiproliferative effect of dietary calcium on colonic epithelium is mediated by luminal surfactants and dependent on the type of dietary fat. Cancer Res (1993) 0.93
Quantitative review of studies of dietary fat and rat colon carcinoma. Nutr Cancer (1991) 0.93
Dairy proteins protect against dimethylhydrazine-induced intestinal cancers in rats. J Nutr (1995) 0.90
Demonstration of the need for end point validation of putative biomarkers: failure of aberrant crypt foci to predict colon cancer incidence. Cancer Res (1991) 0.87
[Colorectal cancer: controversial role of meat consumption]. Bull Cancer (1997) 0.87
Feeding of a well-cooked beef diet containing a high heterocyclic amine content enhances colon and stomach carcinogenesis in 1,2-dimethylhydrazine-treated rats. Nutr Cancer (1998) 0.87
Causes, relevant mechanisms, and prevention of large bowel cancer. Semin Oncol (1991) 0.86
The effect of dietary fat on the promotion of mammary and colon cancer in a dual-organ rat carcinogenesis model. Nutr Cancer (1996) 0.84
Effect of varying proportions of dietary fat on the development of N-nitrosomethylurea-induced rat mammary tumors. Anticancer Res (1986) 0.83
Effect of a diet with high levels of protein and fat on colon carcinogenesis in F344 rats treated with 1,2-dimethylhydrazine. J Natl Cancer Inst (1976) 0.82
Non-promoting effects of lean beef in the rat colon carcinogenesis model. Carcinogenesis (1995) 0.81
Beef tallow, but not corn bran or soybean polysaccharide, reduces large intestinal and fecal bile acid concentrations in rats. Nutr Cancer (1995) 0.81
Correspondence re: J. Shannon et al., Relationship of food groups and water intake to colon cancer risk. Cancer Epidemiol., Biomarkers & Prev., 5: 495-502. Cancer Epidemiol Biomarkers Prev (1997) 0.81
Non-promoting effects of iron from beef in the rat colon carcinogenesis model. Cancer Lett (1997) 0.80
Effect of heat processing and of vegetables and fruit in human diets on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Carcinogenesis (1993) 0.79
BALB/c mice fed milk or beef protein: differences in response to 1,2-dimethylhydrazine carcinogenesis. J Natl Cancer Inst (1983) 0.79
Beta-carotene increases lung cancer incidence in cigarette smokers. Nutr Rev (1996) 0.78
Frequent consumption of red meat is not risk factor for cancer. BMJ (1997) 0.77
[The incidence of 1,2-dimethylhydrazine-induced colonic neoplasms in the rat: the effect of constipation]. G Chir (1992) 0.77
[Interpretation of exhaled CO levels in studies on smoking]. Rev Mal Respir (2010) 1.51
Antibiotic resistance from food. N Engl J Med (1988) 1.47
The effect of bambermycin, carbadox, chlortetracycline and olaquindox on antibiotic resistance in intestinal coliforms: a new animal model. Ann Microbiol (Paris) (1984) 1.09
Simple and ion-pair high performance liquid chromatography as an improved analytical tool for chloramphenicol metabolic profiling. Drug Metab Dispos (1983) 1.07
Insulin injections promote the growth of aberrant crypt foci in the colon of rats. Nutr Cancer (1997) 1.04
Promotion of aberrant crypt foci and cancer in rat colon by thermolyzed protein. J Natl Cancer Inst (1992) 1.02
Antibiotic residues and drug resistance in human intestinal flora. Antimicrob Agents Chemother (1987) 0.98
The COX-2 inhibitor nimesulide suppresses superoxide and 8-hydroxy-deoxyguanosine formation, and stimulates apoptosis in mucosa during early colonic inflammation in rats. Carcinogenesis (2000) 0.95
Endogenous N-nitroso compounds, and their precursors, present in bacon, do not initiate or promote aberrant crypt foci in the colon of rats. Nutr Cancer (2000) 0.94
Diet, aberrant crypt foci and colorectal cancer. Mutat Res (1993) 0.93
Consistent and fast inhibition of colon carcinogenesis by polyethylene glycol in mice and rats given various carcinogens. Cancer Res (2000) 0.90
Polyethylene-glycol suppresses colon cancer and causes dose-dependent regression of azoxymethane-induced aberrant crypt foci in rats. Cancer Res (1999) 0.89
Evaluation of residual and therapeutic doses of tetracycline in the human-flora-associated (HFA) mice model. Regul Toxicol Pharmacol (2001) 0.87
Ecological factors influencing the transfer of plasmids in vitro and in vivo. J Antimicrob Chemother (1986) 0.87
[Colorectal cancer: controversial role of meat consumption]. Bull Cancer (1997) 0.87
Aberrant crypt foci and microadenoma as markers for colon cancer. Environ Health Perspect (1992) 0.87
Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2'-deoxyguanosine, in rat colonic mucosa. Cancer Lett (1998) 0.86
A rare etiology of ischemic colitis - amyloid colitis. Endoscopy (1982) 0.84
Alterations of intestinal microflora by antibiotics. Effects on fecal excretion, transit time, and colonic motility in rats. Dig Dis Sci (1991) 0.82
Cytostatic effect of polyethylene glycol on human colonic adenocarcinoma cells. Int J Cancer (2001) 0.82
The colonic protein fermentation and insulin resistance hypotheses for colon cancer etiology: experimental tests using precursor lesions. Eur J Cancer Prev (1996) 0.82
[Tobacco smoking and latent tuberculous infection]. Rev Mal Respir (2012) 0.81
Potential of semiconductor sensor arrays for the origin authentication of pure Valencia orange juices. J Agric Food Chem (2001) 0.80
Colon tumor promotion: is it a selective process? Effects of cholate, phytate, and food restriction in rats on proliferation and apoptosis in normal and aberrant crypts. Cancer Lett (1997) 0.79
Carrageenan given as a jelly, does not initiate, but promotes the growth of aberrant crypt foci in the rat colon. Cancer Lett (1997) 0.78
Liquid chromatography/electrospray ionisation mass spectrometric tracking of 4-hydroxy-2(E)-nonenal biotransformations by mouse colon epithelial cells using [1,2-13C2]-4-hydroxy-2(E)-nonenal as stable isotope tracer. Rapid Commun Mass Spectrom (2011) 0.78
Antibiotic residues and R-plasmid selection: are in vitro methods good models? Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.78
Carrageenan gel and aberrant crypt foci in the colon of conventional and human flora-associated rats. Nutr Cancer (2000) 0.78
Antibiotic suppression of intestinal microbiota reduces heme-induced lipoperoxidation associated with colon carcinogenesis in rats. Nutr Cancer (2014) 0.77
Pluronic F68 block polymer, a very potent suppressor of carcinogenesis in the colon of rats and mice. Br J Cancer (2001) 0.77
[Prevalence of smoking cessation during pregnancy according to trimester]. Gynecol Obstet Fertil (2006) 0.77
[Tests for evaluating tobacco dependence]. Rev Mal Respir (2012) 0.76
[Light and intermittent tobacco smokers]. Rev Mal Respir (2010) 0.76
[Helping the "hard-core" smokers]. Rev Mal Respir (2012) 0.76
Glycemic index, nutrient density, and promotion of aberrant crypt foci in rat colon. Nutr Cancer (1998) 0.76
Comparative metabolism of chloramphenicol in germfree and conventional rats. Antimicrob Agents Chemother (1983) 0.75
Bioautographic method for evaluation of glycopeptide actaplanin in milk. J Assoc Off Anal Chem (1987) 0.75
Carborundum, a bulk similar to dietary fibers but chemically inert, does not decrease colon carcinogenesis. Cancer Lett (1997) 0.75
[Ocular manifestations in chronic atrophic polychondritis. Apropos of a case report]. Bull Soc Ophtalmol Fr (1985) 0.75
[Eosinophilic ascites. A case report]. Presse Med (1984) 0.75
Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation. Eur J Clin Pharmacol (1993) 0.75
Piroxicam induced pulmonary infiltrates and eosinophilia. J Rheumatol (1994) 0.75
Ranking chemopreventive agents on rat colon carcinogenesis. IARC Sci Publ (2002) 0.75
Urinary and biliary metabolic patterns of chlorothalonil in germ-free and conventional rats. J Agric Food Chem (1999) 0.75
[Clinical practice guideline: medical and nonmedical therapeutic strategies for smoking cessation. Bit of therapeutic practice: management and current practice in smoking cessation]. Rev Mal Respir (2003) 0.75
[Smoking and active tuberculosis]. Rev Mal Respir (2012) 0.75
[Determination of the 13C and 18-0 isotopic composition of carboxylic compounds: application to amino acids]. Int J Appl Radiat Isot (1976) 0.75
["Plastic lung". Broncho-pulmonary pathology related to plastics (author's transl)]. Poumon Coeur (1980) 0.75
R-plasmid transfer and antimicrobial residues in gnotoxenic animal models. J Toxicol Clin Exp (1988) 0.75
Ex vivo gastrointestinal biotransformation of chlorothalonil in the germ-free and conventional rat. Xenobiotica (1998) 0.75
[Cannabis use and impairment of respiratory function]. Rev Mal Respir (2013) 0.75